Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
5.97
-0.02 (-0.33%)
At close: Apr 28, 2026, 4:00 PM EDT
6.00
+0.03 (0.50%)
After-hours: Apr 28, 2026, 7:44 PM EDT
Ardelyx Market Cap
Ardelyx has a market cap or net worth of $1.46 billion as of April 28, 2026. Its market cap has increased by 37.72% in one year.
Market Cap
1.46B
Enterprise Value
1.43B
1-Year Change
37.72%
Ranking
Category
Stock Price
$5.97
Market Cap Chart
Since June 19, 2014, Ardelyx's market cap has increased from $242.70M to $1.46B, an increase of 503.27%. That is a compound annual growth rate of 16.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 1.46B | 3.36% |
| Dec 31, 2025 | 1.42B | 17.95% |
| Dec 31, 2024 | 1.20B | -16.56% |
| Dec 29, 2023 | 1.44B | 169.38% |
| Dec 30, 2022 | 534.30M | 330.89% |
| Dec 31, 2021 | 124.00M | -78.76% |
| Dec 31, 2020 | 583.90M | 23.68% |
| Dec 31, 2019 | 472.10M | 324.55% |
| Dec 31, 2018 | 111.20M | -64.55% |
| Dec 29, 2017 | 313.70M | -53.30% |
| Dec 30, 2016 | 671.70M | 42.82% |
| Dec 31, 2015 | 470.30M | 34.29% |
| Dec 31, 2014 | 350.20M | 44.29% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monte Rosa Therapeutics | 1.52B |
| Immunocore Holdings | 1.46B |
| Damora Therapeutics | 1.46B |
| Agios Pharmaceuticals | 1.45B |
| Wave Life Sciences | 1.45B |
| Biohaven | 1.45B |
| Bicara Therapeutics | 1.44B |
| Maze Therapeutics | 1.43B |